152 related articles for article (PubMed ID: 19713605)
1. Contrast-enhanced ultrasound in diagnosing liver malignancy.
Zuber-Jerger I; Schacherer D; Woenckhaus M; Jung EM; Schölmerich J; Klebl F
Clin Hemorheol Microcirc; 2009; 43(1-2):109-18. PubMed ID: 19713605
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
von Herbay A; Westendorff J; Gregor M
J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
[TBL] [Abstract][Full Text] [Related]
5. Quantitative dynamic contrast-enhanced sonography of hepatic tumors.
Klein D; Jenett M; Gassel HJ; Sandstede J; Hahn D
Eur Radiol; 2004 Jun; 14(6):1082-91. PubMed ID: 15108017
[TBL] [Abstract][Full Text] [Related]
6. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
7. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
[TBL] [Abstract][Full Text] [Related]
8. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
[TBL] [Abstract][Full Text] [Related]
9. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions.
Nicolau C; Vilana R; Catalá V; Bianchi L; Gilabert R; García A; Brú C
AJR Am J Roentgenol; 2006 Jan; 186(1):158-67. PubMed ID: 16357396
[TBL] [Abstract][Full Text] [Related]
10. Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound.
Wang ZL; Tang J; Weskott HP; Li JL; Wang W; Luo YK; An LC; Xu JH
J Gastroenterol Hepatol; 2008 Oct; 23(10):1511-9. PubMed ID: 18713302
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
[TBL] [Abstract][Full Text] [Related]
12. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography.
Kim TK; Jang HJ; Burns PN; Murphy-Lavallee J; Wilson SR
AJR Am J Roentgenol; 2008 Jan; 190(1):58-66. PubMed ID: 18094294
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich C; von Herbay A; Friedrich-Rust M; Kunze G; Becker D; Will U; Kratzer W; Albert FW; Pachmann C; Dirks K; Strunk H; Greis C; Bernatik T
Ultraschall Med; 2008 Oct; 29(5):499-505. PubMed ID: 19241506
[TBL] [Abstract][Full Text] [Related]
14. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
15. Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver.
von Herbay A; Vogt C; Häussinger D
AJR Am J Roentgenol; 2002 Nov; 179(5):1273-9. PubMed ID: 12388513
[TBL] [Abstract][Full Text] [Related]
16. [Value of contrast-enhanced ultrasound in the diagnosis of hepatocarcinoma in focal lesions detected in patients with liver disease].
Gómez Rodríguez RA; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; Repiso Ortega A; Pérez-Grueso Macías MJ; Muñoz Rosas C; Carrobles Jiménez JM
Gastroenterol Hepatol; 2007; 30(7):381-6. PubMed ID: 17692194
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
[TBL] [Abstract][Full Text] [Related]
18. [Contrast-enhanced "low MI real-time" sonography for the assessment of the malignancy of focal liver lesions].
Strunk H; Börner N; Stuckmann G; Fröhlich E; Hadizadeh D
Rofo; 2005 Oct; 177(10):1394-404. PubMed ID: 16170709
[TBL] [Abstract][Full Text] [Related]
19. Software-based quantification of contrast-enhanced ultrasound in focal liver lesions--a feasibility study.
Goertz RS; Bernatik T; Strobel D; Hahn EG; Haendl T
Eur J Radiol; 2010 Aug; 75(2):e22-6. PubMed ID: 19962262
[TBL] [Abstract][Full Text] [Related]
20. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
von Herbay A; Vogt C; Willers R; Häussinger D
J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
